Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
O353308-1mg | 1mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $79.90 | |
O353308-5mg | 5mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $319.90 | |
O353308-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $499.90 |
a species of lysophosphatidic acid containing oleic acid at the sn-1 position
Synonyms | CHEBI:62837 | 1-Oleoyl-sn-glycerol 3-phosphate | 1-Oleoyl-sn-glycero-3-phosphate | LysoPA(18:1) | lysophosphatidic acid | 1-oleylglycerol 3-phosphate | 1-(9Z-octadecenoyl)-sn-glycero-3-phosphate | PA(18:1/0:0) |
---|---|
Specifications & Purity | ≥95%,10mg/ml in ethanol |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | 1-Oleoyl lysophosphatidic acid is a species of lysophosphatidic acid (LPA) containing oleic acid at the sn-1 position. Phosphatidic acid is made either through a two step process involving liberation of diacylglycerol (DAG) by phospholipase C (PLC) follow by phosphorylation of DAG by diglycerol kinase or directly through the action of phospholipase D (PLD). Hydrolysis of the fatty acid at the sn-2 position by phospholipase A2 (PLA2) yields bioactive LPA, which binds to one of five different G protein linked receptors to mediate a variety of biological responses including platelet aggregation, cell proliferation, smooth muscle contraction, cell motility and neurite retraction. 1-Oleoyl lysophosphatidic acid is the most potent of the LPA analogs for calcium mobilization in A431 cells and for growth stimulation of a variety of cell lines. |
pKa | pKₐ: 1.82 (Predicted) |
---|---|
Ki Data | Autotaxin: Ki= 100 nM (human) |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | [(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-9-enoate |
---|---|
INCHI | InChI=1S/C21H41O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)27-18-20(22)19-28-29(24,25)26/h9-10,20,22H,2-8,11-19H2,1H3,(H2,24,25,26)/b10-9-/t20-/m1/s1 |
InChi Key | WRGQSWVCFNIUNZ-GDCKJWNLSA-N |
Canonical SMILES | CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O |
Isomeric SMILES | CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)O)O |
PubChem CID | 5311263 |
UN Number | 1170 |
Packing Group | II |
Molecular Weight | 436.52 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2415512 | Certificate of Analysis | Jul 02, 2024 | O353308 |
G2415514 | Certificate of Analysis | Jul 02, 2024 | O353308 |
G2415517 | Certificate of Analysis | Jul 02, 2024 | O353308 |
G2415519 | Certificate of Analysis | Jul 02, 2024 | O353308 |
H2203639 | Certificate of Analysis | Jun 25, 2022 | O353308 |
H2203640 | Certificate of Analysis | Jun 25, 2022 | O353308 |
H2204022 | Certificate of Analysis | Jun 25, 2022 | O353308 |
H2328035 | Certificate of Analysis | Jun 25, 2022 | O353308 |
Solubility | Soluble in DMSO (~2 mg/ml), DMF (~2 mg/ml), PBS (pH 7.2) (~3 mg/ml), and ethanol. |
---|---|
Refractive Index | n20D1.49 (Predicted) |
Boil Point(°C) | 78° C |
Pictogram(s) | GHS05, GHS02 |
---|---|
Signal | Danger |
Hazard Statements | H319:Causes serious eye irritation H225:Highly Flammable liquid and vapor |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P370+P378:In case of fire: Use ... to extinguish. P210:Keep away from heat, hot surface, sparks, open flames and other ignition sources. - No smoking. P501:Dispose of contents/container to ... P233:Keep container tightly closed. P240:Ground/bond container and receiving equipment. P264:Wash hands [and …] thoroughly after handling. P403+P235:Store in a well-ventilated place. Keep cool. P303+P361+P353:IF ON SKIN (or hair): Take off Immediately all contaminated clothing. Rinse SKIN with water [or shower]. P241:Use explosion-proof [electrical/ventilating/lighting/.../] equipment. P337+P313:IF eye irritation persists: Get medical advice/attention. P242:Use only non-sparking tools. P243:Take precautionary measures against static discharge. |
Class | 3 |
1. Xiaoyang Sun, Lifen Zhang, Shaojun Tian, Kaizhou Yang, Jianchun Xie. (2020) Phospholipid composition and emulsifying properties of rice bran lecithin from enzymatic degumming. LWT-FOOD SCIENCE AND TECHNOLOGY, 117 (108588). [PMID:] [10.1016/j.lwt.2019.108588] |
1. Xiaoyang Sun, Lifen Zhang, Shaojun Tian, Kaizhou Yang, Jianchun Xie. (2020) Phospholipid composition and emulsifying properties of rice bran lecithin from enzymatic degumming. LWT-FOOD SCIENCE AND TECHNOLOGY, 117 (108588). [PMID:] [10.1016/j.lwt.2019.108588] |